UMN Pharma Inc. | Income Statement
Fiscal year is January-December. All values JPY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
93
1,109
203
53
104
104
Cost of Goods Sold (COGS) incl. D&A
1,432
2,047
1,577
51
3
2
Gross Income
1,338
939
1,374
1
101
102
SG&A Expense
3,084
3,004
1,833
553
599
709
EBIT
4,422
3,943
3,207
-
498
607
Unusual Expense
-
247
-
-
-
81
Non Operating Income/Expense
506
139
32
7,794
349
36
Interest Expense
226
168
151
1
9
3
Pretax Income
4,140
4,002
3,390
8,347
158
727
Consolidated Net Income
4,222
4,006
3,390
8,344
159
729
Net Income
3,717
3,961
3,390
8,344
159
729
Net Income After Extraordinaries
3,717
3,961
3,390
8,344
159
729
Net Income Available to Common
3,717
3,961
3,390
8,344
159
729
EPS (Basic)
491.59
452.34
354.16
804.39
12.96
55.12
Basic Shares Outstanding
8
9
10
10
12
13
EPS (Diluted)
491.59
452.34
354.16
804.39
12.96
55.12
Diluted Shares Outstanding
8
9
10
10
12
13
EBITDA
3,018
2,069
1,683
552
498
607
Non-Operating Interest Income
-
-
-
-
1
-
Minority Interest Expense
505
45
-
-
-
-
About UMN Pharma
View Profile
